Exicure (XCUR) Cash from Investing Activities Growth (3y) (2019 - 2025)
Exicure (XCUR) Cash from Investing Activities Growth (3y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
116.52% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
38.24% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Exicure |
17.53 Mn |
14.92 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
30.02% |
| Sep 30, 2025 |
-52.35% |
| Jun 30, 2025 |
-29.81% |
| Mar 31, 2025 |
-44.98% |
| Dec 31, 2023 |
-62.49% |
| Jun 30, 2023 |
-36.36% |
| Mar 31, 2023 |
26.17% |
| Dec 31, 2022 |
26.06% |
| Sep 30, 2022 |
65.04% |
| Jun 30, 2022 |
209.70% |
| Mar 31, 2022 |
531.11% |
| Dec 31, 2021 |
423.73% |
| Sep 30, 2021 |
862.19% |
| Jun 30, 2021 |
585.84% |
| Dec 31, 2020 |
310.87% |
| Jun 30, 2020 |
195.28% |
| Mar 31, 2020 |
-270.92% |
| Dec 31, 2019 |
-827.19% |
